Description: Ziccum AB (publ) develops dry powder preparations of biological pharmaceuticals. It develops and commercializes LaminarPace, a spray drying technology that dries liquid biopharmaceuticals, such as vaccines or protein therapeutics into a particle engineered powder product. The company was incorporated in 2017 and is headquartered in Lund, Sweden.
Home Page: ziccum.com
Scheelevägen 22
Lund,
223 63
Sweden
Phone:
46 7 09 61 55 99
Officers
Name | Title |
---|---|
Ms. Ann Gidner | Chief Exec. Officer |
Ms. Frida Hjelmberg | Chief Financial Officer |
Mr. Fabrice Rose | Scientific Director |
Exchange: ST
Country: SE : Sweden
Currency: Swedish krone (kr)
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0.8073 |
Price-to-Sales TTM: | 2382.5972 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 8 |